Maria Cecilia Artigas, DO | |
171 Ashley Ave, Charleston, SC 29425-8908 | |
(843) 792-1414 | |
Not Available |
Full Name | Maria Cecilia Artigas |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 15 Years |
Location | 171 Ashley Ave, Charleston, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992937635 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 0102202653 (Virginia) | Secondary |
207W00000X | Ophthalmology | 39088 (South Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Brad D. Simons, Md,phd, Pa | 5496906703 | 2 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
Maintaining a healthy lifestyle significantly decreases the risk for stroke in both men and women who differ in their hypertension status and use of antihypertensive drug treatments, a study shows.
"United Nations aid agencies said Friday more than five million Pakistanis are in need of humanitarian assistance following the floods earlier this year," with nearly half of those being children, the VOA "Breaking News" blog reports (11/26).
A recent study discloses that loss of taste and smell sensation after infection with SARS-CoV-2 negatively impacts the quality of life and psychological wellbeing of those that recover but experience persistence of this symptom.
› Verified 3 days ago
Entity Name | Brad D. Simons, Md,phd, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477806115 PECOS PAC ID: 5496906703 Enrollment ID: O20121114000594 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
Maintaining a healthy lifestyle significantly decreases the risk for stroke in both men and women who differ in their hypertension status and use of antihypertensive drug treatments, a study shows.
"United Nations aid agencies said Friday more than five million Pakistanis are in need of humanitarian assistance following the floods earlier this year," with nearly half of those being children, the VOA "Breaking News" blog reports (11/26).
A recent study discloses that loss of taste and smell sensation after infection with SARS-CoV-2 negatively impacts the quality of life and psychological wellbeing of those that recover but experience persistence of this symptom.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Maria Cecilia Artigas, DO Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Maria Cecilia Artigas, DO 171 Ashley Ave, Charleston, SC 29425-8908 Ph: (843) 792-1414 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
Maintaining a healthy lifestyle significantly decreases the risk for stroke in both men and women who differ in their hypertension status and use of antihypertensive drug treatments, a study shows.
"United Nations aid agencies said Friday more than five million Pakistanis are in need of humanitarian assistance following the floods earlier this year," with nearly half of those being children, the VOA "Breaking News" blog reports (11/26).
A recent study discloses that loss of taste and smell sensation after infection with SARS-CoV-2 negatively impacts the quality of life and psychological wellbeing of those that recover but experience persistence of this symptom.
› Verified 3 days ago
Kenneth A Sharpe, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3531 Mary Ader Ave, Charleston, SC 29414 Phone: 843-352-0674 | |
Dr. Andrew Steven Eiseman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Scott Alan Davis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Hao Tang, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 167 Ashley Ave # Msc676, Charleston, SC 29425 Phone: 843-792-2020 Fax: 843-792-1166 | |
M Edward Wilson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Edward William Trudo Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
John Weaver, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |